Literature DB >> 20140651

Potential physiological effects of pharmaceutical compounds in Atlantic salmon (Salmo salar) implied by transcriptomic analysis.

Miriam Hampel1, Esteban Alonso, Irene Aparicio, James E Bron, Juan Luis Santos, John B Taggart, Michael J Leaver.   

Abstract

BACKGROUND, AIM, AND SCOPE: Pharmaceuticals are emerging pollutants widely used in everyday urban activities which can be detected in surface, ground, and drinking waters. Their presence is derived from consumption of medicines, disposal of expired medications, release of treated and untreated urban effluents, and from the pharmaceutical industry. Their growing use has become an alarming environmental problem which potentially will become dangerous in the future. However, there is still a lack of knowledge about long-term effects in non-target organisms as well as for human health. Toxicity testing has indicated a relatively low acute toxicity to fish species, but no information is available on possible sublethal effects. This study provides data on the physiological pathways involved in the exposure of Atlantic salmon as representative test species to three pharmaceutical compounds found in ground, surface, and drinking waters based on the evaluation of the xenobiotic-induced impairment resulting in the activation and silencing of specific genes.
MATERIALS AND METHODS: Individuals of Atlantic salmon (Salmo salar) parr were exposed during 5 days to environmentally relevant concentrations of three representative pharmaceutical compounds with high consumption rates: the analgesic acetaminophen (54.77+/-34.67 microg L(-1)), the anticonvulsant carbamazepine (7.85+/-0.13 microg L(-1)), and the beta-blocker atenolol (11.08+/-7.98 microg L(-1)). Five immature males were selected for transcriptome analysis in brain tissues by means of a 17k salmon cDNA microarray. For this purpose, mRNA was isolated and reverse-transcribed into cDNA which was labeled with fluorescent dyes and hybridized against a common pool to the arrays. Lists of significantly up- and down-regulated candidate genes were submitted to KEGG (Kyoto Encyclopedia of Genes and Genomes) in order to analyze for induced pathways and to evaluate the usefulness of this method in cases of not completely annotated test organisms.
RESULTS: Exposure during 5 days to environmentally relevant concentrations of the selected pharmaceutical compounds acetaminophen, carbamazepine, and atenolol produced differences in the expression of 659, 700, and 480 candidate genes, respectively. KEGG annotation numbers (KO annotations) were obtained for between 26.57% and 33.33% of these differently expressed genes per treatment in comparison to non-exposure conditions. Pathways that showed to be induced did not always follow previously reported targets or metabolic routes for the employed treatments; however, several other pathways have been found (four or more features) to be significantly induced. DISCUSSION: Energy-related pathways have been altered under exposure in all the selected treatments, indicating a possible energy budget leakage due to additional processes resulting from the exposure to environmental contaminants. Observed induction of pathways may indicate additional processes involved in the mode of action of the selected pharmaceuticals which may not have been detected with conventional methods like quantitative PCR in which only suspected features are analyzed punctually for effects. The employment of novel high-throughput screening techniques in combination with global pathway analysis methods, even if the organism is not completely annotated, allows the examination of a much broader range of candidates for potential effects of exposure at the gene level.
CONCLUSIONS: The continuously growing number of annotations of representative species relevant for environmental quality testing is facilitating pathway analysis processes for not completely annotated organisms. KEGG has shown to be a useful tool for the analysis of induced pathways from data generated by microarray techniques with the selected pharmaceutical contaminants acetaminophen, carbamazepine, and atenolol, but further studies have to be carried out in order to determine if a similar expression pattern in terms of fold change quantity and pathways is observed after long-term exposure. Together with the information obtained in this study, it will then be possible to evaluate the potential risk that the continuous release of these compounds may have on the environment and ecosystem functioning.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140651     DOI: 10.1007/s11356-009-0282-6

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  29 in total

1.  The KEGG databases at GenomeNet.

Authors:  Minoru Kanehisa; Susumu Goto; Shuichi Kawashima; Akihiro Nakaya
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

2.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance.

Authors:  Dana W Kolpin; Edward T Furlong; Michael T Meyer; E Michael Thurman; Steven D Zaugg; Larry B Barber; Herbert T Buxton
Journal:  Environ Sci Technol       Date:  2002-03-15       Impact factor: 9.028

3.  Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt.

Authors:  T Kitamura; Y Kitamura; S Kuroda; Y Hino; M Ando; K Kotani; H Konishi; H Matsuzaki; U Kikkawa; W Ogawa; M Kasuga
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters.

Authors:  W Z Potter; S S Thorgeirsson; D J Jollow; J R Mitchell
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

5.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo.

Authors:  D J Jollow; J R Mitchell; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

6.  Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity.

Authors:  D Schmoll; K S Walker; D R Alessi; R Grempler; A Burchell; S Guo; R Walther; T G Unterman
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

7.  GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization.

Authors:  A Tarze; A Deniaud; M Le Bras; E Maillier; D Molle; N Larochette; N Zamzami; G Jan; G Kroemer; C Brenner
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

8.  Waterborne and sediment toxicity of fluoxetine to select organisms.

Authors:  Bryan W Brooks; Philip K Turner; Jacob K Stanley; James J Weston; Elizabeth A Glidewell; Christy M Foran; Marc Slattery; Thomas W La Point; Duane B Huggett
Journal:  Chemosphere       Date:  2003-07       Impact factor: 7.086

Review 9.  Aquatic ecotoxicology of fluoxetine.

Authors:  Bryan W Brooks; Christy M Foran; Sean M Richards; James Weston; Philip K Turner; Jacob K Stanley; Keith R Solomon; Marc Slattery; Thomas W La Point
Journal:  Toxicol Lett       Date:  2003-05-15       Impact factor: 4.372

10.  A description of the origins, design and performance of the TRAITS-SGP Atlantic salmon Salmo salar L. cDNA microarray.

Authors:  J B Taggart; J E Bron; S A M Martin; P J Seear; B Høyheim; R Talbot; S N Carmichael; L A N Villeneuve; G E Sweeney; D F Houlihan; C J Secombes; D R Tocher; A J Teale
Journal:  J Fish Biol       Date:  2008-06       Impact factor: 2.051

View more
  1 in total

Review 1.  Microbe mediated remediation of dyes, explosive waste and polyaromatic hydrocarbons, pesticides and pharmaceuticals.

Authors:  Deepanshu Monga; Paramdeep Kaur; Baljinder Singh
Journal:  Curr Res Microb Sci       Date:  2021-12-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.